Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype.
To assess the role of the alpha1b-adrenergic receptor (AR) in glucose homeostasis, we investigated glucose metabolism in knockout mice deficient of this receptor subtype (alpha1b-AR-/-). Mutant mice had normal blood glucose and insulin levels, but elevated leptin concentrations in the fed state. During the transition to fasting, glucose and insulin blood concentrations remained markedly elevated for at least 6 h and returned to control levels after 24 h whereas leptin levels remained high at all times. Hyperinsulinemia in the post-absorptive phase was normalized by atropine or methylatropine indicating an elevated parasympathetic activity on the pancreatic beta cells, which was associated with increased levels of hypothalamic NPY mRNA. Euglycemic clamps at both low and high insulin infusion rates revealed whole body insulin resistance with reduced muscle glycogen synthesis and impaired suppression of endogenous glucose production at the low insulin infusion rate. The liver glycogen stores were 2-fold higher in the fed state in the alpha1b-AR-/- compared with control mice, but were mobilized at the same rate during the fed to fast transition or following glucagon injections. Finally, high fat feeding for one month increased glucose intolerance and body weight in the alpha1b-AR-/-, but not in control mice. Altogether, our results indicate that in the absence of the alpha1b-AR the expression of hypotalamic NPY and the parasympathetic nervous activity are both increased resulting in hyperinsulinemia and insulin resistance as well as favoring obesity and glucose intolerance development during high fat feeding.
Institute of Pharmacology and Toxicology, Lausanne, Switzerland.
Rémy
R
Burcelin
Marc
M
Uldry
Marc
M
Foretz
Christophe
C
Perrin
Anabela
A
Dacosta
Monique
M
Nenniger-Tosato
Josiane
J
Seydoux
Susanna
S
Cotecchia
Bernard
B
Thorens
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D005934:Glucagon / Q000737:chemistry; D005947:Glucose / Q000378:metabolism*; D006003:Glycogen / Q000378:metabolism; D006706:Homeostasis; D006946:Hyperinsulinism; D007333:Insulin Resistance; D020738:Leptin / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008817:Mice, Mutant Strains; D008820:Mice, Obese; D012333:RNA, Messenger / Q000378:metabolism; D011941:Receptors, Adrenergic / Q000378:metabolism; D018340:Receptors, Adrenergic, alpha-1 / Q000235:genetics* / Q000502:physiology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013997:Time Factors
C547717:Adra1b protein, mouse; D001786:Blood Glucose; D020738:Leptin; D012333:RNA, Messenger; D011941:Receptors, Adrenergic; D018340:Receptors, Adrenergic, alpha-1; D006003:Glycogen; D005934:Glucagon; D005947:Glucose